S&P 500   3,666.72 (-0.06%)
DOW   29,969.52 (+0.29%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
S&P 500   3,666.72 (-0.06%)
DOW   29,969.52 (+0.29%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
S&P 500   3,666.72 (-0.06%)
DOW   29,969.52 (+0.29%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
S&P 500   3,666.72 (-0.06%)
DOW   29,969.52 (+0.29%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
Log in
NYSE:PRGO

Perrigo Stock Forecast, Price & News

$48.33
+0.37 (+0.77 %)
(As of 12/3/2020 04:15 PM ET)
Add
Compare
Today's Range
$47.76
Now: $48.33
$48.56
50-Day Range
$41.29
MA: $46.51
$49.19
52-Week Range
$40.01
Now: $48.33
$63.86
Volume901,730 shs
Average Volume1.03 million shs
Market Capitalization$6.60 billion
P/E Ratio27.78
Dividend Yield1.88%
Beta1.15
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid, 24HR, Good Sense, Zephrex D, ScarAway, Plackers, and Rembrandt. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands and consumer focused products through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Perrigo logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.25 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71429010
Phone353-1709-4000
Employees11,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.84 billion
Cash Flow$7.32 per share
Book Value$42.64 per share

Profitability

Net Income$146.10 million

Miscellaneous

Market Cap$6.60 billion
Next Earnings Date2/25/2021 (Estimated)
OptionableOptionable
$48.33
+0.37 (+0.77 %)
(As of 12/3/2020 04:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Perrigo (NYSE:PRGO) Frequently Asked Questions

How has Perrigo's stock been impacted by Coronavirus (COVID-19)?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PRGO shares have increased by 5.0% and is now trading at $48.33.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Perrigo?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Perrigo
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Perrigo?

Wall Street analysts have given Perrigo a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Perrigo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Perrigo
.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) announced its earnings results on Wednesday, November, 4th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.84 by $0.09. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.23 billion. Perrigo had a net margin of 4.73% and a return on equity of 10.05%. The business's quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.04 earnings per share.
View Perrigo's earnings history
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, October 22nd. Investors of record on Friday, November 27th will be paid a dividend of $0.225 per share on Tuesday, December 15th. This represents a $0.90 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Wednesday, November 25th.
View Perrigo's dividend history
.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY20 earnings guidance on Wednesday, November, 4th. The company provided EPS guidance of $3.95 to $4.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.07. The company issued revenue guidance of $5.127 billion to $5.176 billion, compared to the consensus revenue estimate of $5.02 billion.

What price target have analysts set for PRGO?

7 Wall Street analysts have issued twelve-month target prices for Perrigo's stock. Their forecasts range from $49.00 to $70.00. On average, they expect Perrigo's stock price to reach $58.33 in the next year. This suggests a possible upside of 20.7% from the stock's current price.
View analysts' price targets for Perrigo
.

Are investors shorting Perrigo?

Perrigo saw a increase in short interest in November. As of November 15th, there was short interest totaling 3,620,000 shares, an increase of 13.8% from the October 31st total of 3,180,000 shares. Based on an average trading volume of 896,200 shares, the days-to-cover ratio is currently 4.0 days.
View Perrigo's Short Interest
.

Who are some of Perrigo's key competitors?

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

Who are Perrigo's key executives?

Perrigo's management team includes the following people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 60, Pay $3.06M)
  • Mr. Raymond P. Silcock, CFO, Principal Accounting Officer & Exec. VP (Age 69, Pay $1.48M)
  • Mr. James E. Dillard III, Exec. VP & Chief Scientific Officer (Age 56, Pay $1.01M)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 58, Pay $1.08M)
  • Mr. Ronald C. Janish, Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain (Age 54)
  • Mr. Shannon Hukill, Sr. Director of Technical Operations
  • Mr. Thomas M. Farrington, Chief Information Officer & Exec. VP (Age 63)
  • Mr. Bradley Joseph, VP of Global Investor Relations & Corp. Communications
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 60)
  • Ms. Mary Reilly-Brest, Director of Global Organizational and Human Resource Devel.

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.47%), State Street Corp (4.65%), Camber Capital Management LP (2.09%), Nuveen Asset Management LLC (1.68%), Sound Shore Management Inc CT (1.60%) and Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.58%). Company insiders that own Perrigo stock include Grainne Quinn, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo
.

Which institutional investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Sound Shore Management Inc CT, Point72 Asset Management L.P., Diamond Hill Capital Management Inc., Manning & Napier Group LLC, Sector Gamma AS, ArrowMark Colorado Holdings LLC, Franklin Street Advisors Inc. NC, and Charles Schwab Investment Management Inc..
View insider buying and selling activity for Perrigo
.

Which institutional investors are buying Perrigo stock?

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Menora Mivtachim Holdings LTD., Camber Capital Management LP, State of Tennessee Treasury Department, AQR Capital Management LLC, BlackRock Inc., Nuveen Asset Management LLC, First Trust Advisors LP, and Harel Insurance Investments & Financial Services Ltd.. Company insiders that have bought Perrigo stock in the last two years include Svend Andersen, and Theodore R Samuels II.
View insider buying and selling activity for Perrigo
.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $48.33.

How big of a company is Perrigo?

Perrigo has a market capitalization of $6.60 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,000 workers across the globe.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.